Literature DB >> 22707501

Acquired-transient factor X deficiency in a teenager with extensive burns.

Andreia Mascarenhas1, Marilene Eusébio, Orquídea Freitas, Teresa Almeida.   

Abstract

Acquired factor X deficiency is an extremely rare situation. It has shown to be associated with systemic amyloidosis, respiratory mycoplasma infection, factor X inhibitors, antiphospholipid antibodies, vitamin K deficiency/liver disease as well as the use of certain medications (meropenem, valproic acid). The pathogenesis and transient nature of this deficit remain poorly understood. The authors describe the case of a teenager hospitalised for extensive burns that developed active bleeding after removal of central venous catheter. He was diagnosed with transient factor X deficiency. Normalisation of coagulation status and factor X levels occurred spontaneously 10 days after the bleeding episode.

Entities:  

Mesh:

Year:  2011        PMID: 22707501      PMCID: PMC3062893          DOI: 10.1136/bcr.12.2010.3618

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Acquired inhibitors to factors V and X after exposure to topical thrombin: interference with monitoring of low molecular weight heparin and warfarin.

Authors:  S J Israels; M T Leaker
Journal:  J Pediatr       Date:  1997-09       Impact factor: 4.406

2.  Transient selective factor X deficiency in a severely burned child.

Authors:  Serge Jennes; Ghuider Saidane; Jean-Philippe Fauville; Michel Ledoux; Benoît Colinet
Journal:  Burns       Date:  2007-10-04       Impact factor: 2.744

3.  Acquired and transient factor X deficiency associated with sodium valproate treatment.

Authors:  V Gallais; H Bredoux; G le Roux; L Laroche
Journal:  Eur J Haematol       Date:  1996-10       Impact factor: 2.997

Review 4.  Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.

Authors:  J Hirsh; T E Warkentin; S G Shaughnessy; S S Anand; J L Halperin; R Raschke; C Granger; E M Ohman; J E Dalen
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

5.  Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy.

Authors:  E B Choufani; V Sanchorawala; T Ernst; K Quillen; M Skinner; D G Wright; D C Seldin
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

6.  Acquired-transient factor X deficiency associated with anticardiolipin antibodies in a child with extensive burns.

Authors:  Mehmet Haberal; Ozgür Basaran; Ayşe E Sakallioğlu; Emine Kesik; Bülent Alioğlu; Namik Ozbek
Journal:  J Burn Care Res       Date:  2006 Jan-Feb       Impact factor: 1.845

Review 7.  Factor X deficiency.

Authors:  James Uprichard; David J Perry
Journal:  Blood Rev       Date:  2002-06       Impact factor: 8.250

8.  Acquired, transient factor X (Stuart factor) deficiency in patient with mycoplasma pneumonial infection.

Authors:  F W Peuscher; W G van Aken; J A van Mourik; A J Swaak; L H Sie; L W Statius van Eps
Journal:  Scand J Haematol       Date:  1979-10

9.  An acquired inhibitor to factor X in a pediatric patient with extensive burns.

Authors:  A T Matsunaga; F E Shafer
Journal:  J Pediatr Hematol Oncol       Date:  1996-05       Impact factor: 1.289

  9 in total
  2 in total

1.  Successful treatment of a noninhibitory antibody-mediated acquired factor X deficiency in a patient with marginal-zone lymphoma.

Authors:  Annemarie Meenhuis; Rianne van Vliet; Francisca Hudig; Paula F Ypma; Martin R Schipperus; Martine J Hollestelle
Journal:  Clin Case Rep       Date:  2015-05-25

2.  Hypocoagulation induced by broad-spectrum antibiotics in extensive burn patients.

Authors:  Jian Liu; Yiqing Liu; Shengjun Liu; Qin Zhang; Jiexin Zheng; Yiwen Niu; Xuefeng Wang
Journal:  Burns Trauma       Date:  2019-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.